Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement

Cancer Treat Res. 1988:38:265-83. doi: 10.1007/978-1-4613-1713-5_9.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Acute Disease
  • Adult
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Neoplasm / immunology*
  • Antigens, Differentiation / immunology
  • Antigens, Neoplasm / immunology
  • Bone Marrow / pathology
  • Bone Marrow Transplantation*
  • Child
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Complement System Proteins / immunology*
  • Hematopoietic Stem Cells / immunology
  • Humans
  • Immunotoxins / pharmacology
  • Immunotoxins / therapeutic use
  • Leukemia / immunology
  • Leukemia / pathology
  • Leukemia / surgery*
  • Leukemia / therapy
  • Lymphocyte Depletion*
  • Lymphocytes / immunology
  • Lymphoma, Non-Hodgkin / immunology
  • Lymphoma, Non-Hodgkin / pathology
  • Lymphoma, Non-Hodgkin / surgery*
  • Lymphoma, Non-Hodgkin / therapy
  • Neoplastic Stem Cells / drug effects
  • Neoplastic Stem Cells / immunology
  • Neoplastic Stem Cells / pathology*
  • Transplantation, Autologous

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neoplasm
  • Antigens, Differentiation
  • Antigens, Neoplasm
  • Immunotoxins
  • Complement System Proteins